Foresite Capital Management III as of March 31, 2019
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 19 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 24.1 | $93M | 2.0M | 47.50 | |
| Immunomedics | 12.0 | $46M | 2.4M | 19.21 | |
| Alder Biopharmaceuticals | 10.4 | $40M | 2.9M | 13.65 | |
| Blueprint Medicines (BPMC) | 9.7 | $37M | 468k | 80.05 | |
| Ascendis Pharma A S (ASND) | 6.2 | $24M | 204k | 117.70 | |
| Cymabay Therapeutics | 5.5 | $21M | 1.6M | 13.28 | |
| Arcus Biosciences Incorporated (RCUS) | 4.4 | $17M | 1.4M | 12.49 | |
| Myokardia | 4.2 | $16M | 314k | 51.99 | |
| Aimmune Therapeutics | 3.8 | $15M | 647k | 22.35 | |
| Epizyme | 3.2 | $12M | 998k | 12.39 | |
| Audentes Therapeutics | 3.2 | $12M | 315k | 39.02 | |
| Acceleron Pharma | 3.1 | $12M | 255k | 46.57 | |
| Replimune Group (REPL) | 3.1 | $12M | 750k | 15.83 | |
| Wave Life Sciences (WVE) | 1.7 | $6.4M | 165k | 38.85 | |
| Tocagen | 1.6 | $6.2M | 568k | 10.87 | |
| Natera (NTRA) | 1.4 | $5.2M | 252k | 20.62 | |
| Biohaven Pharmaceutical Holding | 1.0 | $3.9M | 76k | 51.47 | |
| BioDelivery Sciences International | 0.9 | $3.3M | 630k | 5.30 | |
| Achaogen | 0.3 | $1.3M | 2.9M | 0.46 |
